Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Breast Lesion Localization Methods Market Worth $1.57 Billion by 2025: Grand View Research, Inc.

Grand View Research
Posted on: 31 Jul 17

SAN FRANCISCO, July 31, 2017 /PRNewswire/ --

The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according to a new report by Grand View Research, Inc. The increasing government and non-government reimbursement policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations, and other treatment options is estimated to increase the adoption of breast lesion localization procedures. For instance, the Alabama Breast and Cervical Cancer Early Detection Program aims to provide breast and cervical oncology diagnostic and screening services to women who meet certain income, age, and insurance coverage eligibility guidelines.

Furthermore, rising prevalence of breast cancer is anticipated to propel the market growth. The disease is highly prevalent amongst women belonging to the age group of 65 years or above. The maximum risk of mammary gland cancer is between the age of 70 and 79. On the other hand, men are also at a risk of breast cancer. In the U.S., median age of men at diagnosis is approximately 68 years.

Browse full research report with TOC on "Breast Lesion Localization Methods Market Size & Forecast By Type (Wire Localization Biopsy, Radioisotope Localization, Radio-Guided Occult-lesion Localization (ROLL), Radioactive Seed Localization (RSL), Magnetic Tracer), And Trend Analysis, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market

Further key findings from the report suggest: 

Wire localization biopsy dominated the market in 2016 owing to its higher usage by healthcare practitioners, easy availability, and presence of a wide product range

Magnetic tracer is expected to grow at lucrative CAGR of 14.0% over the forecast period as a result of increasing adoption of MagSNOLL technology over conventional wire localization.

Radioisotope seed localization is considered the most preferred method amongst all radioisotope localization methods due to its benefits such as ease of localization few weeks before the excision surgery and lesser need for reoperation.

North America is estimated to be the largest regional market. It dominated the market in terms of revenue with USD 185.04 million in 2016 owing to the presence of well-established healthcare services and increasing number of oncology surgeries being performed.

In addition, early adoption of devices and shift from traditional to technologically advanced products by healthcare providers are some of the factors anticipated to increase the demand for localization devices in this region

Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to growing awareness about breast screening among the people. Furthermore, presence of a large target population and rising disposable income are some of the factors expected to propel the growth of this region.

Key players in this industry are Cianna Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.

Most of the key players are focusing on strategies such as expansion of their product portfolios and collaborations, mergers, & acquisitions. In November 2015, C.R. BARD, Inc. announced the acquisition of Liberator Medical Holdings, Inc., a direct-to-customer distributor of medical products.

Browse related reports by Grand View Research: 

Remanufactured Medical Imaging Devices Market - http://www.grandviewresearch.com/industry-analysis/remanufactured-medical-imaging-devices-market

Ultrasound Market - http://www.grandviewresearch.com/industry-analysis/ultrasound-market

Metabolic Testing Market - http://www.grandviewresearch.com/industry-analysis/metabolic-testing-market-analysis-market

Angiography Device Market - http://www.grandviewresearch.com/industry-analysis/angiography-device-market

Grand View Research has segmented the global breast lesion localization methods market on the basis of type and region: 

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million, 2014 - 2025) 

Wire Localization biopsy

Radioisotope localization

Radio-guided occult lesion localization

Radioactive seed localization

Others

Magnetic tracer

Others

Breast Lesion Localization Methods Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025) North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

Japan

China

India

Latin America

Brazil

Mexico

Middle East & Africa

South Africa 

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: +1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.